Trial NCT05780541

View at ClinicalTrials.gov 
Org. Study IDs: 014/ACTIV-3/H6

Last trial update was posted on 2024-02-09

MeSH Interventions

Remdesivir

MeSH Conditions

COVID-19

Other Conditions


Stopping Reasons

The agent was withdrawn from development by the manufacturer after being placed on clinical hold by the US FDA.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID